Nova BioGenetics Inc. (fka NVBG)

[MicrobeGuard]

Patents can not infringe another Patent. BUT just because you have a patent, does not mean that your patent really works nor does it meant that you manufacture your product as the patent defines.

Their patents really do create a product, but that product does not create an antimicrobial that is effective. In fact, in many cases the patented product performs worse than if you never applied the patented product in the first place. This is how and why the trouble started in the first place.

Since Nova's patented products were not effective, they had to violate the Emory patent. How? They manufactured a product using the Emory patent and claimed that they were using their patent. Who would know? Well we tested the product and were able to clearly prove that their products infringed the Emory Patents.

Nova's patents and EPa registration are currently owned by the IBCL trustee who did auction them off at a public auction, but the party who won the bid has not purchsed the patents as of yet.